Laddar...
Once-monthly risedronate for postmenopausal osteoporosis
Bisphosphonates are the mainstay of treatment for postmenopausal women with osteoporosis. Despite numerous clinical trials documenting efficacy, tolerability, and safety of bisphosphonate therapy, long-term persistence and adherence to these agents remains low. This has serious consequences for pati...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2971711/ https://ncbi.nlm.nih.gov/pubmed/21072270 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|